Add to Favourites
To login click here
This article discusses the use and limitations of artificial intelligence (AI) in precision medicine for oncology research and treatment. It highlights the benefits of personalized medicine and the potential of AI-based chatbots in improving anti-cancer outcomes. The article also addresses current challenges and suggests regulatory implementations to enhance the performance of AI algorithms in the future.
